INCOME FOR THE YEAR GROWTH 7.05% IN 2015, PT Enseval Putera Megatrading Tbk SHARE CASH DIVIDEND BY RP 5 – PER SHARE

Press Release

INCOME FOR THE YEAR GROWTH 7.05% IN 2015,
PT Enseval Putera Megatrading Tbk SHARE CASH DIVIDEND BY RP 5 – PER SHARE
Press Release No.002 / EPMT / CSEC / VI / 2016

Jakarta, May 25, 2016 – On Wednesday, May 25, 2016, PT Enseval Putera Megatrading Tbk (the “Company”) has held a General Meeting of Shareholders (AGM), held in EPM Function Room, Building A, Second Floor, Jalan Rawa Gelam IV No. 6, Pulogadung Industrial Estate, East Jakarta. As stated by the President of the Company, Mr. Hartono Djonny Tjahyadi, the Performance Report of the Company for the year 2015, the Company achieved an increase in Current Year Profit amounted to 7.05%, to Rp Rp547,17 billion of Rp511,12 billion in 2014. For that , based on the decision of the AGM, the Company will distribute cash dividends of Rp 5, – per share to the holders of 2.70864 billion shares.

Increased Earnings Current Year the Company was not in spite of the increased sales of the Company Neto. Net sales of the Company at the end of 2015 stood at Rp17.476,10 billion, an increase of 2.73% when compared to Net sales in 2014 were recorded at Rp17.011,55 billion. Cost of Sales The Company itself grew by 1.89%, to Rp15.366,26 billion, of Rp15.081,77 billion at the end of 2014. Cost of Sales Ratio to Net Sales at the end of 2015 reached 87.93%, decreased 0.73% when compared to the end of 2014 it stood at 88.66%. Thus the Company has achieved record growth of 9.33% Gross Profit, be Rp2.109,84 billion of Rp1.929,78 billion in 2014

Operating expenses at the end of 2015 stood at Rp1.403,20 billion, consisting of Selling Expenses amounted Rp1.207,78 billion and General and Administrative Expenses amounted Rp195,43 billion. Accordingly, the Company can be recorded Operating Income at the end of 2015 amounted to Rp706,64 billion, an increase of 9.19% when compared to Operating Profit in 2014 amounted Rp647,19 billion.

At the end of 2015, the Company also recorded: Financial income amounted Rp49,81 billion, amounting to 13.04 billion Financial Expenses, Other Operating Income amounted Rp27,93 billion, Final Tax Expense amounted Rp10,01 billion, and Other Operating Expenses amounted to Rp24, 43 billion. At the end of 2015 the Company also recorded an Income Tax Expense, Net of Rp189,73 billion.

From the comparison of Consolidated Financial Position Report dated December 31, 2015 to December 31, 2014, the Company’s total assets increased to Rp6.747,94 billion from Rp6.196,98 billion, or an increase of 8.89%. Total liabilities of the Company rose by 0.43% from Rp 2666.25 billion up to the end of 2014 to Rp2.677,69 billion by the end of 2015. Shareholders’ equity increased by 15.28% from Rp3.530,73 billion up to the end of 2014 to Rp4.070,25 billion by the end of 2015.

Each Performance – Each Division

The Company has seven (7) Division, which consists of the Consumer Products Division, with Prescription Drugs, OTC, Raw Materials for sale and Equipment Health, Medicine Veterinary and Livestock, as well as Health Care Services.

As for the details rather than the performance of each division of the Company can be described as follows:

Consumer Goods Division
At the end of 2015, the division recorded net sales of consumer goods amounted to Rp7.517,61 billion, down 0.19% from the end of 2014 it stood at Rp 7531.55 billion. Division of consumer goods accounted for 43.02% of the Company’s total net sales.

Division of Drugs with Prescription
The net sales of the division of prescription drugs increased by 0.79% from Rp4.730,29 billion at year-end 2014 to Rp4.767,87 billion by the end of 2015, contributing 27.28% of the Company’s total net sales.

Division of Non Prescription
OTC drugs division contributed 15.54% of the Company’s total net sales in 2015. Sales of OTC drugs reach Rp2.716,20 billion, showing an increase of 3.43% compared to 2014 reaching Rp2.626,07 billion.

Division Raw Materials For Sale
In 2015, the sales division of raw materials for sale totaled Rp1.349,75 billion, a growth of 1.69% compared with the end of 2014 which reached Rp1.327,35 billion. This division accounted for 7.72% of the total net sales.

Medical Equipment Division
Medical equipment division experienced a significant increase in 2015, amounting to 45.88%, with net sales reaching Rp1.082,14 billion compared to the achievement in 2014 amounted Rp741,78 billion. Medical equipment division contributed 6.19% of the Company’s total net sales.

Pharmaceuticals Division Animals and Livestock
In 2015, veterinary medicines and livestock division posted net sales amounted Rp36,05 billion, decreased by 25.96% compared to 2014 reaching Rp48,69 billion. Drug division animals and livestock accounted for 0.21% of the total net sales.

Health Care Services
By 2015, health care services through the clinic Mitrasana posted net sales amounted Rp6,47 billion, an increase of 11.38% compared to 2014 reaching Rp5,81 billion. Health services division accounted for 0.04% of the total net sales.

Based on the AGM, resulting decisions are as follows:

1. To approve and ratify the Annual Report for the fiscal year ended on December 31, 2015, including the report of activities of the Company, the Board of Commissioners Supervisory Report and Financial Statements Years ended on December 31, 2015, as well as providing release and discharge full responsibility ( acquit et de charge) to the Board of Directors and Board of Commissioners for the actions of management and supervision they did in the fiscal year ended on December 31, 2015 all those actions are reflected in the Annual Report;
2. a. Approved the use of the advantages of the Company on profit for the year attributable to owners of Parent Entity for the financial year 2015, amounting to Rp. 547,124,228,884.00 (five hundred and forty-seven billion, one hundred and twenty four million two hundred twenty eight thousand eight hundred and eighty four Rupiah), to establish its use as follows:
i. Rp. 13,543,200,000.00 (thirteen billion, five hundred and forty three million two hundred thousand Rupiah) or 2.475% (two point four seven five percent), as cash dividend to be distributed to holders of 2.70864 billion (two billion, seven hundred and eight million six hundred forty thousand) shares, so that each share will receive a cash dividend of Rp5,00 (five Rupiah);
ii. Rp. 5,471,242,289.00 (five billion, four hundred and seventy-one two hundred and forty-two thousand two hundred and eighty-nine Rupiah), set aside as a reserve fund;
iii. The rest of the current year profit of Rp. 528,109,786,595.00 (five hundred twenty eight billion, one hundred and nine million seven hundred and eighty-six thousand five hundred ninety five Rupiah), recorded as retained earnings;
2. b. Authorize and authorize the Board of Directors to perform any and all actions necessary to the cash dividend, including but not limited to schedule the time, date and method of payment of the cash dividend;
3. To authorize the Board of Commissioners to determine the salaries and allowances for members of the Board of Directors and Board of Commissioners, with regard to the recommendation of the Remuneration Committee;
4. Provide authority and power to the Board of Commissioners and / or Board of Directors to appoint an Independent Public Accountant who will audit the Financial Statements of the Company’s books for the fiscal year ended December 31, 2016, and authorized the Board of Directors to determine the fees the Independent Public accountant as well as other requirements such appointment.

About Enseval

Enseval is the largest distribution company in Indonesia which has started distribution activities since 1973 and has more than 6435 employees. Company Enseval be open on August 1, 1994 under the name PT Putera Megatrading Enseval Tbk (IDX: EPMT). In addition to distributing products from Kalbe Group, Enseval also trusted by the principal-other principals from both inside and outside the country. The Company has an extensive distribution network with 2 Regional Distribution Centre (RDC) located in Jakarta and Surabaya, 46 branches spread across the Indonesian archipelago and 25 other branches through the Subsidiary PT Tri Sapta Jaya. Until now, the Company has six subsidiaries, is engaged in the distribution, raw materials, medical devices, and healthcare services.

Jakarta, May 27, 2016
———————————

Baca Juga

Convocation to the 2021 EPMT EGMS

February 3, 2021

Direksi PT Enseval Putera Megatrading Tbk dengan ini mengundang para pemegang saham Perseroan untuk menghadiri Rapat Umum Pemegang Saham Luar Biasa, yang akan diadakan pada: Hari/Tanggal : Kamis, 25 Februari 2021.

Read More

the Company’s net sales grew by 11.86%

October 31, 2014

the profit of the current year on the 30th of September 2014 stood at Rp355,04 billion

Read More